Solventum Corporation
Maplewood, Minnesota health care company spun off from 3M in 2024, operating across medical-surgical, dental, health information systems, and filtration.
Company Type
public
Founded
2024
Headquarters
Maplewood, Minnesota, USA
Stock
New York Stock Exchange: SOLV
Revenue
$8.3 billion (FY2025)
Employees
Approximately 22,000
Primary Market
Global
Solventum Corporation Timeline
Shop Solventum Corporation Brands
Disclosure: We may earn commission from purchases
About Solventum Corporation
Is Solventum part of 3M?
No. It was spun off as an independent public company in April 2024, though 3M retained a stake being sold down.
Is Solventum publicly traded?
Yes. It trades on the NYSE under ticker SOLV and is in the S&P 500.
Who is the CEO of Solventum?
Bryan Hanson, former Zimmer Biomet CEO, who has led since the spin-off.
What does Solventum make?
Medical-surgical supplies, dental products, health information software, and filtration products.
History of Solventum Corporation
The business descends from 3M's health care division, which assembled wound care, dental, and medical software operations over decades, including the acquisitions of Acelity (KCI wound care, $6.7 billion in 2019) and earlier dental and coding businesses.
When 3M decided to focus on industrial and consumer franchises, it spun the health care operations into Solventum in April 2024, retaining a minority stake that it has been selling down. Bryan Hanson, the former Zimmer Biomet CEO, took the top job to run the turnaround.
The first standalone years have been an integration and separation sprint: more than 1,000 IT systems to split from 3M, distribution centers being consolidated from 3M's network, a SKU rationalization program, and a formal long-range plan built on five growth drivers expected to deliver over 80 percent of future growth.
Solventum Corporation Sustainability & Ethics
The company publishes health care-specific sustainability reporting covering product safety, access, and manufacturing standards under FDA and international device regulation.
Brands Owned by Solventum Corporation
Solventum Corporation owns 2 brands in our database. Explore the ownership tree below — click categories to expand and see individual brands.
Solventum Corporation
public · Founded 2024 · Maplewood, Minnesota, USA
2
brands
Stock Information
Solventum Corporation Ownership: Pros & Cons
Advantages
- +Category-leading consumables like Tegaderm and Bair Hugger
- +Post-spin focus and dedicated leadership driving margin improvement
- +Portfolio reshaping toward five growth drivers
- +Acera acquisition adds regenerative wound care growth
Considerations
- -Separation execution risk across IT and supply chain
- -Legacy 3M liabilities retained at spin, including PFAS-related allocations
- -Commodity product categories face price pressure
- -Purification divestiture reduces near-term revenue
Frequently Asked Questions About Solventum Corporation
Is Solventum part of 3M?
No. It was spun off as an independent public company in April 2024, though 3M retained a stake being sold down.
Is Solventum publicly traded?
Yes. It trades on the NYSE under ticker SOLV and is in the S&P 500.
Who is the CEO of Solventum?
Bryan Hanson, former Zimmer Biomet CEO, who has led since the spin-off.
What does Solventum make?
Medical-surgical supplies, dental products, health information software, and filtration products.
Sources & Further Reading
Jobs at Solventum Corporation
Latest News About Solventum Corporation
Related Articles About Solventum Corporation
View more articles
Monthly IPO Roundup: November 2026 -- October's Biggest Listings
October 2026 IPOs: Jio Platforms set India's all-time record at $3.2B and surged 27%, GCash owner Mynt raised a Philippine-record P60.9B, Anthropic filed publicly for a possible mid-November debut, and U.S. listings were a biotech grab bag. Full recap.
Monthly M&A Roundup: October 2026 Brand Ownership Changes
October 2026's biggest deals: Paramount Skydance closed its $110B Warner Bros. Discovery takeover, Salesforce signed Braze for $5.66B, Proofpoint bought Varonis for $6.3B, the Weston family agreed to buy Boots for $8.9B, and Viatris added Pacira for $1.65B. Full breakdown.
Duracell vs Energizer: The Battery Brand Rivalry
Duracell is Berkshire Hathaway-owned (25-30% US share). Energizer is publicly traded (NYSE: ENR) with Rayovac. Together they control ~85% of branded US batteries, but Amazon Basics has 27.1% online. Explore our database.
Related Companies to Solventum Corporation
View more companies
Baxter International Inc.
Medical products company focused on hospital products, connected care, and pharmaceuticals after divesting its kidney care and biopharma businesses.
1 brand in portfolio
Biogen Inc.
Global biotechnology company headquartered in Cambridge, Massachusetts, focused on neurology products including Spinraza, Tysabri, Skyclarys, Zurzuvae, and Leqembi.
6 brands in portfolio
Boston Scientific Corporation
Global medical device company founded in 1979 and headquartered in Marlborough, Massachusetts, known for cardiovascular, Watchman, and neuromodulation products.
1 brand in portfolio
The Cooper Companies, Inc.
Global medical device company operating through CooperVision contact lenses and CooperSurgical fertility and women's health. Public on Nasdaq under COO.
1 brand in portfolio
Danaher Corporation
American multinational life sciences and diagnostics company operating Biotechnology, Life Sciences, and Diagnostics segments, publicly traded on the NYSE.
9 brands in portfolio
DuPont
American diversified industrial company specializing in technology-based materials and solutions for healthcare, water, construction, aerospace, and industrial markets.
15 brands in portfolio